Treatment that interferes with inhibitory immune regulatory interactions, such as PD-1/PD-L1 or CTLA-4-associated restraint. It requires a usable antitumour recognition and effector system.

Ancestors (4)

  1. Immunology
  2. Medicine
  3. Biology
  4. Home

Incoming links (3)

View article source

Discussion (0) New discussion

There are no discussions about this article yet.

Articles by others on the same topic (0)

There are currently no matching articles.
See all articles in the same topic Create my own version